(1035–1045) Spondyloarthritis Including PsA – Treatment Poster II: Mixed

Sunday, November 13, 2022

9:00 AM – 10:30 AM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

9:00 AM – 10:30 AM Eastern Time

Efficacy of Guselkumab in Three Cohorts of Biologic-Naïve PsA Patients with Axial Involvement Defined Based on Imaging and Machine-Learning Criteria: Pooled Analysis of Two Phase 3 Studies
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
9:00 AM – 10:30 AM Eastern Time

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by History of Cigarette Smoking
Abstract Poster Presenter: Alexis Ogdie, MD – University of Pennsylvania
9:00 AM – 10:30 AM Eastern Time

Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies
Abstract Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
9:00 AM – 10:30 AM Eastern Time

Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Ankylosing Spondylitis
Abstract Poster Presenter: Arthur Kavanaugh, MD – UCSD
9:00 AM – 10:30 AM Eastern Time

Differential Retention of Adalimumab and Etanercept Biosimilars Compared to Originator Treatments: Results of a Retrospective French Multicentre Study
Abstract Poster Presenter: Guillaume LARID, MD, MSc – CHU de Poitiers
9:00 AM – 10:30 AM Eastern Time

Impact of Weight and Sex on Long-term Persistence to Secukinumab Treatment in Patients with Active Psoriatic Arthritis or Ankylosing Spondylitis
Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet
9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis
Abstract Poster Presenter: Atul Deodhar, MD – Oregon Health & Science University
9:00 AM – 10:30 AM Eastern Time

Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis
Abstract Poster Presenter: Jan Brandt-Juergens, MD – rheumatologische Schwerpunktpraxis
9:00 AM – 10:30 AM Eastern Time

Combined Biological or Targeted Therapy in Spondyloarthritis: Experience from a Multicenter Case Series in Spain
Abstract Poster Presenter: Cristina Valero, MD – Hospital de la Princesa
9:00 AM – 10:30 AM Eastern Time

Quantification of the Enthesic Response to Biological Therapies in Patients with Spondyloarthritis by Computer Analysis of Ultrasound Images
Abstract Poster Presenter: Marina Tortosa-Cabañas, MD – Ramon y Cajal University Hospital